Community/Retail

Sixty years after the first hormonal birth control pill was marketed to women, men still have limited options with variable efficacy for birth control.

It is vital to consult with a health care provider before taking OTC vitamins and supplements.

Pharmacists are uniquely positioned to interact with patients who may be seeking an OTC drug or supplement as first-line therapy for short sleep duration.

Worldwide, the human immune system tends to make the same antibodies when targeting viruses, which can modify their structure to avoid detection.

VAX-24 is designed to prevent invasive pneumococcal disease and pneumonia, which can be most serious for infants, young children, older adults, and those with immune deficiencies or some chronic health conditions.

Host Christina Madison, PharmD, BCACP, AAHIVP, sat down with Jeffrey Bratberg, PharmD, FAPhA, a clinical professor in the college of pharmacy at the University of Rhode Island

Amazon says new prescription service overcomes cost and insurance barriers for patients.

An Independent Data Monitoring Committee recommends stopping 2 phase 3 trials early for efficacy following positive results in November 2022.

Building strong, trusting relationships helps combat hesitancy, creating healthier communities.

Agency updates emergency use authorization for the Moderna and Pfizer-BioNTech COVID-19 vaccinations, which are no longer authorized for used in the United States.

Atypical respiratory syncytial virus epidemics may continue, and testing patients for multiple respiratory pathogens when indicated might be necessary.

Neurovascular mechanisms cause the decrease in BP levels, results from a study of 23 participants in Brazil show.

The findings could inform revisions to safety guidelines and policies that help protect people with cardiovascular issues during heat waves.

The Apothecary Shoppe in Utah knows patients by name, garners new business via word of mouth.

Findings show that study participants experienced improvements in both blood sugar control and the lipid profile.

Atogepant (Qulipta; AbbVie) is the first and only oral calcitonin gene-related peptide receptor antagonist to gain FDA approval for the prevention of episodic and chronic migraine.

A new scientific statement from the American Heart Association notes that the process falls short for those who are not white.

The efficacy and tolerability of rizatriptan for acute migraine treatment has been well established.

Other health essentials, such as groceries, prescriptions, some OTC medications, are tax-exempt in many states.

The 2 most hypervirulent strains of Clostridioides difficile are associated with the consumption of pork and shellfish.

Respiratory syncytial virus (RSV) vaccine demonstrated efficacy of 66.7% in reducing RSV-associated lower respiratory tract illness with at least 2 signs or symptoms in older adults.

The data support the use of interventions at home, including frequent handwashing, physical distancing, regular surface disinfection, and wearing a mask.

Being observant and knowing how to ask screening questions are critical to identifying red flags.

Establish procedures, including training employees, to address shortages, back-order situations.

Susan Koletar, MD, FACP, FIDSA, director of the Division of Infectious Diseases at the Ohio State University College of Medicine, discusses the pharmacists’ role in addressing vaccine hesitancy and improving global vaccine rates.

A linear mixed-effect model for repeated estimated glomerular filtration rate measurements at baseline and a follow-up visit, up to 5 years after baseline, shows results.

41% of patients report moderate-to-severe issues, with Black individuals 3 times more likely to develop these difficulties.

For chronic cases, encourage patients to seek medical care from their primary health care providers.

Pharmacy professionals can bring in the right people at the right time to identify needed changes and develop an action plan.

Patients administered anakinra did not meet a study’s primary endpoint of proportion of patients who did not need mechanical ventilation 15 days after starting treatment for severe COVID-19 pneumonia.